{
  "abstract": "Inflammatory bowel disease (IBD) can impact reproductive planning. Achieving disease remission prior to conception is advised, as it can reduce risks for both the mother and the infant. Flare-ups during pregnancy can lead to complications, such as preterm birth. Therefore, managing the disease effectively with the right medications is crucial for optimal outcomes. Most IBD medications (except small molecules and methotrexate) carry minimal risks to the fetus and are safe during breastfeeding, so it is important for individuals to understand the potential dangers of discontinuing treatment and the significance of maintaining remission. Given the rapid change in medical therapies, this review highlights the latest evidence to ensure successful pregnancy outcomes.",
  "authors": [
    {
      "affiliations": [
        "Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana, USA"
      ],
      "name": "Katherine Westbrook Cates"
    },
    {
      "affiliations": [
        "Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana, USA"
      ],
      "name": "Nisha Loganantharaj"
    },
    {
      "affiliations": [
        "University of Cincinnati, Cincinnati, Ohio, USA"
      ],
      "name": "Kara De Felice"
    }
  ],
  "title": "Pregnancy in IBD: keeping mom healthy for a healthy baby",
  "uid": "8fe17997-6e4e-5818-a6e3-f553355bccb9"
}